Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy
Krause, A.; Gerber, B.
Zentralblatt für Gynakologie 116(1): 44-47
1994
ISSN/ISBN: 0044-4197 PMID: 8147180 Document Number: 425312
Report about 8 patients with endometrial pathology during tamoxifen therapy: 1 endometrial cancer, 1 adenomyosis uteri and 6 endometrial polyps. The knowledge about effects of tamoxifen on endometrium and possibilities of prevention are discussed. Sonographic screening of patients during tamoxifen therapy and if need by endometrial biopsy is necessary especially if tamoxifen is given longer than 2 years. No more than 30 mg should given in adjuvant therapy.
Document emailed within 1 workday
Related Documents
Sinawat, S.; Chiyabutra, T.; Kleabkaew, P. 2001: Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report Journal of the Medical Association of Thailand 84(7): 1033-1036Sinawat, S.; Chiyabutra, T. 2004: Endometrial thickening in postmenopausal breast cancer patients taking tamoxifen: a cross-sectional study Journal of the Medical Association of Thailand 87 Suppl. 3: S59-S63
Kochar, S.; Arora, P.; Chattopadhyay, A.B. 2005: Tamoxifen Therapy for Breast Cancer and Endometrial Pathology Medical Journal Armed Forces India 61(4): 313-315
Steiner, A. 1999: Transvaginal endometrial sonography in postmenopausal women taking tamoxifen Obstetrics and Gynecology 94(2): 321-322
Novoa Vargas, A.; Font López, K.C.; Amador, D.D. 2011: Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer Ginecologia y Obstetricia de Mexico 79(9): 553-557
Neri, F.; Maggino, T. 2009: Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment European Journal of Gynaecological Oncology 30(4): 357-360
Look, K.; Sanders, B.; Eastlund, M.; Sutton, G. 1999: Detection of endometrial adenocarcinoma in two asymptomatic postmenopausal women receiving tamoxifen. A report of two cases Journal of Reproductive Medicine 44(11): 977-980
Bardi, M.; Arnoldi, E.; Pizzocchero, G.; Pezzica, E.; Mattioni, D.; Perotti, M. 1994: Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with tamoxifen adjuvant therapy for breast cancer. A case report European Journal of Gynaecological Oncology 15(5): 393-395
Arteaga-Gómez, A.C.; Castellanos-Barroso, G.; Colin-Valenzuela, A.; García-Vargas, J.; Márquez-Acosta, G.; Reyes-Muñoz, E. 2011: Hormone therapy effect in postmenopausal women with history of endometrial cancer Ginecologia y Obstetricia de Mexico 79(1): 11-17
Kahraman, K.; Pabuccu, E.; Taskin, S.; Sukur, Y.E.; Ozmen, B.; Ortac, F. 2011: The role of ultrasound and symptom-based triage for detection of pathological endometrial changes in patients undergoing tamoxifen therapy for breast cancer European Journal of Gynaecological Oncology 32(6): 667-671
Güven, M.A.; Pata, O.; Bakaris, S.; Kafkasli, A.; Mgoyi, L. 2004: Postmenopausal endometrial cancer screening: is there a correlation between transvaginal sonographic measurement of endometrial thickness and body mass index? European Journal of Gynaecological Oncology 25(3): 373-375
Arnold, A. 1994: More on endometrial cancer and tamoxifen Journal of the National Cancer Institute 86(24): 1877-1878
Neven, P. 1991: Endometrial changes in patients receiving tamoxifen therapy New York State Journal of Medicine 91(4): 168
Gori, S.; Anastasi, P.; Marrocolo, F. 2004: Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer: the MA-17 study I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S27-S31
Powles, T.J.; Gordon, C.; Coombes, R.C. 1982: Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-aminoglutethimide-danazol compared to tamoxifen used alone Cancer Research 42(8 Suppl): 3458s-3460s
Baldini, B.; Taddei, G.L.; Tiso, E.; Visioli, C.B.; Campos, K.J.; Napolitano, A.C.; Tantini, C. 1996: Hysteroscopic evaluation of the endometrium in 63 postmenopausal patients treated with tamoxifen for breast cancer Minerva Ginecologica 48(6): 259-262
Elhelw, B.; Ghorab, M.N.; Farrag, S.H. 1999: Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 67(2): 81-86
Bhatavdekar, J.M.; Shah, N.G.; Patel, D.D.; Karelia, N.H.; Trivedi, S.N.; Vora, H.H.; Ghosh, N.; Giri, D.D.; Balar, D.B. 1992: Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifen Neoplasma 39(2): 123-127
Machin, D.; Andersen, K.W. 1997: Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer Journal of the National Cancer Institute 89(9): 659-660
Gershanovich, M.L.; Garin, A.M.; Baltinia, D.; Kurvet, A.; Kangas, L.; Ellmen, I. 1997: Results of phase Ii clinical trial of Tamoxifen and Toremifen in two different doses in advanced breast cancer in postmenopausal women Voprosy Onkologii 43(6): 587-595